SCHEMBL16397847

SCHEMBL16397847

CCOC=Cc1cc(CO)nc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16397923 0.84 ALDH1A1 (0.37) —
SCHEMBL21194413 0.80 KMT2A (0.37) —
SCHEMBL31093340 0.80 KMT2A (0.37) —
SCHEMBL16398103 0.78 — —
SCHEMBL16397703 0.78 — —
SCHEMBL16398386 0.77 HTR2A (0.31) —
SCHEMBL16397917 0.77 — —
SCHEMBL16398519 0.76 — —
SCHEMBL16398283 0.76 — —
SCHEMBL16398495 0.74 NQO2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004079-A1 PYRIMIDINE COMPOUNDS AND THEIR USE AS GAMMA SECRETASE MODULATORS Acturum Life Science AB (SE) 2016-04-13 — — EP disclosed
WO-2014195323-A1 PYRIMIDINE COMPOUNDS AND THEIR USE AS GAMMA SECRETASE MODULATORS Acturum Life Science AB (SE) 2014-12-11 — — WO disclosed
Send feedback